Akacid-medical-formulation, a novel biocidal oligoguanidine with antitumor activity reduces S-phase in prostate cancer cell lines through the Erk 1/2 mitogen-activated protein kinase pathway
Hannes Neuwirt(Innsbruck Medical University), Zoran Čulig(Innsbruck Medical University)
Cited by 6
Related Papers
Cancer-associated fibroblasts promote prostate tumor growth and progression through upregulation of cholesterol and steroid biosynthesis
|Cell Communication and Signaling|2020|105
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
|Endocrine Related Cancer|2005|94
Suppressor of Cytokine Signaling (SOCS)-1 Is Expressed in Human Prostate Cancer and Exerts Growth-Inhibitory Function through Down-Regulation of Cyclins and Cyclin-Dependent Kinases
|American Journal Of Pathology|2009|67
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
|Endocrine Related Cancer|2012|65
Suppressor of Cytokine Signaling-3 Antagonizes cAMP Effects on Proliferation and Apoptosis and Is Expressed in Human Prostate Cancer
|American Journal Of Pathology|2006|59